Intelligence. Accountability. Analysis.
Est. 2022 · Washington, D.C.
The Congressional Times
We follow the data, not the narrative
◆ Live Intelligence
Loading...
Analysis Loading today's analysis...
Politics

Senate Democrats Cite Loopholes in Blanche Deal on Anti-Weaponization Fund

The agreement's unresolved language on a $1.776 billion fund and attorney general immunity provisions creates measurable legislative ambiguity that may require further Senate action to resolve.

The Congressional Times · August 4, 2026

Senate Democrats raised objections Tuesday to a deal involving Acting Attorney General Todd Blanche, asserting that the agreement failed to eliminate a $1.776 billion anti-weaponization fund and left intact a broad immunity order shielding Blanche from government investigation into his past conduct, according to reporting by The Hill published August 4, 2026. Democrats used the term 'loophole' repeatedly during floor discussions to characterize what they described as gaps in the agreement's enforcement language.

The $1.776 billion figure attached to the anti-weaponization fund is drawn from publicly available appropriations documents; the precise statutory authorization and line-item budget allocation for that fund have not been independently confirmed in a finalized congressional record as of this publication. The source of the fund's legal authority and which agency administers it remains unspecified in currently available public reporting.

The immunity provision at issue stems from a directive issued by Blanche in his capacity as acting attorney general. The scope of that order — described as granting immunity from any government investigation into his past conduct — has not been published in full text in the Federal Register as of August 4, 2026, according to available public records. The Hill's report indicates Senate Democrats view the deal as insufficiently curtailing that order, though the specific legislative mechanism they sought was not identified in the available source material.

Republican reaction to the Democratic objections was not detailed in the available source reporting as of publication time. The Congressional Times has not independently confirmed whether any Republican senators endorsed, opposed, or remained neutral on the deal's final terms.

What remains unknown: the complete text of Blanche's immunity directive, the appropriations line item or continuing resolution provision funding the $1.776 billion anti-weaponization fund, and the specific amendment language Senate Democrats proposed to close the cited loopholes. The full Senate debate record in the Congressional Record for August 4-5, 2026, and any published Office of Legal Counsel memoranda related to the immunity order would be the primary documents to resolve these open questions.

Today's Analysis
Loading...
Latest Intelligence
Congressional Intelligence
Loading...
Financial Intelligence
Loading...
Geopolitical Intelligence
Loading...
Follow the MoneyGab-E Political Intelligence Investigation
Loading...
Opinion & Analysis
Loading...
Archive
Loading...
About
Our Mission

We Follow the Data, Not the Narrative

The Congressional Times exists because public records are public — and the analysis built from them should not be exclusive to those who can afford $60,000-a-year intelligence subscriptions.

Every story published in The Congressional Times is sourced to a verifiable public record: a court filing, a Senate lobbying disclosure, an FEC contribution record, a USASpending contract, or a verified news report. We state our sources inline. We show our math. When we are wrong, we say so publicly.

We do not editorialize in news coverage. We do not use loaded language. Both political parties are held to identical standards.

The Follow the Money investigations are the heart of this publication. Each begins with Gab-E Political Intelligence running against 10+ million government records before a single word of editorial is written.

Powered by Gab-E, an elite global intelligence platform built to democratize political and financial intelligence.

Editorial Policy
Editorial Standards & Corrections Policy

How We Source, Verify, and Correct Our Work

Every factual claim in a Congressional Times story is checked against a primary source: a government filing, a court record, a direct quote, before publication. When a claim can't be verified or doesn't hold up as originally reported, we drop it or reframe it. We do not publish disputed claims as settled fact.

When we get it wrong: we correct the story directly, note the correction and date at the bottom of the piece, and update the record. We do not quietly edit and move on.

Bylines: stories with a named byline are written and fact-checked by that person. Stories without a byline are sourced from Gab-E Political Intelligence, our automated research platform, and are labeled as such.

Ownership: The Congressional Times is published by Gab-E Holdings LLC. Gab-E, our intelligence platform, powers our sourcing and research pipeline.

Corrections or concerns: support@gab-e.com